Wells Fargo
HSCS icon

Wells Fargo’s Heart Test Laboratories HSCS Stock Holding History

Wells Fargo’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63 Buy
+25
New +$73 ﹤0.01% 6560
2024
Q2 		– Sell
-5
Closed -$53 – 7138
2024
Q1 		$53 Buy
5
+4
+400% +$52 ﹤0.01% 6811
2023
Q4 		$11 Hold
1
– – ﹤0.01% 7365
2023
Q3 		$24 Buy
+1
New +$78 ﹤0.01% 7136
2023
Q2 		– Hold
0
– – – 7302
2023
Q1 		– Hold
0
– – – 7486
2022
Q4 		– Hold
0
– – – 7383
2022
Q3 		– Hold
0
– – – 6937

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wells Fargo's HSCS Position: Q1 2026 in Review

Wells Fargo opened a new position in Heart Test Laboratories (HSCS) in Q1 2026: 25 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #6560 among its holdings. This is a return to the name: Wells Fargo previously reported a position in HSCS as recently as Q1 2024.

Wells Fargo first reported a position in HSCS in Q3 2023 and has held it in 4 quarters since. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • Wells Fargo held 25 shares of Heart Test Laboratories worth $63 as of Q1 2026.
  • Heart Test Laboratories was a new Wells Fargo position in Q1 2026.
  • Heart Test Laboratories made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6560 holding.
  • Wells Fargo first reported a position in Heart Test Laboratories in Q3 2023 and has held it in 4 quarters since.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.